Varas-Lorenzo C, Riera-Guardia N, Calingaert B, Margulis A, Pladevall M, Miguel G, Romio S, Sturkenboom M, Perez-Gutthann S. Cardiovascular risk with glitazones and metformin: results from a systematic review of observational studies. Poster presented at the 29th International Conference on Pharmacoepidemiology and Therapeutic Risk Management; August 2013. [abstract] Pharmacoepidemiol Drug Saf. 2013 Oct 7; 22(S1):68.
Varas-Lorenzo C, Riera Guardia N, Castellsague J, Arfe A, Perez-Gutthann S. The SOS project: risk of heart failure and use of nonsteroidal anti-inflammatory drugs. A meta-analysis of observational studies. Poster presented at the 29th International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2013. [abstract] Pharmacoepidemiol Drug Saf. 22(S1):67.
Varas-Lorenzo C, Riera-Guardia N, Calingaert B, Castellsague J, Salvo F, Nicotra F, Sturkenboom M, Perez-Gutthann S. Myocardial infarction and individual nonsteroidal anti-inflammatory drugs meta-analysis of observational studies. Pharmacoepidemiol Drug Saf. 2013 Jun;22(6):559-70.
Castellsague J, Riera-Guardia N, Calingaert B, Varas-Lorenzo C, Fourrier-Reglat A, Nicotra F, Sturkenboom M, Perez-Gutthann S. Individual NSAIDS and upper gastrointestinal complications: a systematic review and meta-analysis of observational studies (the SOS project). Drug Saf. 2012 Dec 1;35(12):1127-46.
Varas-Lorenzo C, Riera-Guardia N, Calingaert B, Castellsague J, Pariente A, Scotti L, Sturkenboom M, Perez-Gutthann S. Stroke risk and NSAIDs: a systematic review of observational studies. Pharmacoepidemiol Drug Saf. 2011 Dec 1;20(12):1225-36.
Riera-Guardia N, Hirst C, Castellsague J, Varas-Lorenzo C, Pariente A, Sturkenboom MCJM, Perez-Gutthann S. The SOS project: cardiovascular and gastrointestinal safety of NSAIDS. Preliminary results of a systematic review of epidemiological studies. Poster presented at the 25th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2009. Providence, RI. [abstract] Pharmacoepidemiol Drug Saf. 2009 Aug 16; 18(Suppl 1):S207.